FDA Week - 11/30/2018

Gottlieb: Drug Shortages Are Result Of Economic, Policy Failures

By Beth Wang / November 27, 2018 at 5:00 PM
Continuing drug shortage issues are a result of economic and policy failures that span many years, FDA Commissioner Scott Gottlieb told a crowd of researchers, health care providers, industry representatives and other experts during the agency’s Tuesday (Nov. 27) drug shortages public meeting, held in coordination with the Duke Margolis Center for Health Policy. In a discussion guide released in advance of the Tuesday meeting , Duke echoes some of the same root causes cited by Gottlieb, and adds that...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.